MARIETTA, Ga., Sept. 29, 2015 /PRNewswire/ — MiMedx Group, Inc. MDXG, -1.16%the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental